We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

32 hedge funds and large institutions have $4.85M invested in Tonix Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,976% more capital invested

Capital invested by funds: $158K → $4.85M (+$4.69M)

400% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 4

100% more funds holding

Funds holding: 16 → 32 (+16)

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

0.07% more ownership

Funds ownership: 0.01% → 0.08% (+0.07%)

Holders
32
Holders Change
+16
Holders Change %
+100%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
6
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.23M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$386K
3
Jane Street
Jane Street
New York
+$340K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$332K
5
UBS Group
UBS Group
Switzerland
+$318K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$16.1K
2
VF
Virtu Financial
New York
-$15K
3
TRCT
Tower Research Capital (TRC)
New York
-$5.3K
4
MG
Marex Group
-$4.88K
5
LPL Financial
LPL Financial
California
-$3.12K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$3.47K +$2.18K +105 New
MCI
27
MRP Capital Investments
Georgia
$3.3K – – –
WAP
28
Wealthcare Advisory Partners
Pennsylvania
$3.3K +$2.08K +100 New
NSIM
29
North Star Investment Management
Illinois
$1.74K +$1.1K +53 New
SS
30
SBI Securities
Japan
$1.24K +$790 +38 New
Bank of America
31
Bank of America
North Carolina
$501 +$270 +13 +650%
AIM
32
Anchor Investment Management
South Carolina
$38 +$21 +1 New
DB
33
Danske Bank
Denmark
$5 – – –
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$3 – – –
AF
35
Allworth Financial
California
$1 – – –
FDCDDQ
36
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1 – – –
GRP
37
Global Retirement Partners
California
$1 – – –
TRCT
38
Tower Research Capital (TRC)
New York
– -$5.3K -356 Closed
VPIM
39
Vanguard Personalized Indexing Management
California
– -$2.26K -152 Closed
JF
40
Jump Financial
Illinois
– -$1.66K -112 Closed
CTC
41
Central Trust Company
Missouri
– -$1 – –
1
2

TNXP Hedge Fund Activity: Q4 2024 in Review

32 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q4 2024, worth a combined $4.85M — up 2,976% from $158K a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TNXP positions and 4 closed out — a net gain of 16 holders — while 6 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, adding an estimated $1.23M. The largest seller was Millennium Management, cutting an estimated $16.1K.

  • 32 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q4 2024, up from 16 in Q3 2024.
  • Funds reported $4.85M of Tonix Pharmaceuticals stock for Q4 2024, up 2,976% quarter-over-quarter.
  • 20 funds opened new Tonix Pharmaceuticals positions in Q4 2024 and 4 closed out, a net change of +16 holders.
  • The largest Tonix Pharmaceuticals buyer in Q4 2024 was BlackRock, an estimated $1.23M added.
  • The largest Tonix Pharmaceuticals seller in Q4 2024 was Millennium Management, an estimated $16.1K sold.

Based on aggregated 13F filings for Q4 2024.